Drugs / Еnoxaparin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04461925 Background | May 2020 → May 2021 | pneumonia | Institute of Cell Therapy | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Еnoxaparin | “Еnoxaparin” NCT04461925 ↗ |